Like it or not, life-extension research extends beyond biogerontology.
作者信息
de Grey Aubrey D N J
出版信息
EMBO Rep. 2005 Nov;6(11):1000. doi: 10.1038/sj.embor.7400565.
Abstract
摘要
相似文献
1
Like it or not, life-extension research extends beyond biogerontology.
EMBO Rep. 2005 Nov;6(11):1000. doi: 10.1038/sj.embor.7400565.
2
Hormesis in biogerontology.
Crit Rev Toxicol. 2001 Jul;31(4-5):663-4. doi: 10.1080/20014091111929.
3
Science fact and the SENS agenda. What can we reasonably expect from ageing research?
EMBO Rep. 2005 Nov;6(11):1006-8. doi: 10.1038/sj.embor.7400555.
4
Developing a research agenda in biogerontology: basic mechanisms.
Sci Aging Knowledge Environ. 2005 Nov 2;2005(44):pe33. doi: 10.1126/sageke.2005.44.pe33.
5
Experimental aging research.
Exp Aging Res. 2010 Oct;36(4):393. doi: 10.1080/0361073X.2010.511538.
6
Comparative cellular biogerontology: primer and prospectus.
Ageing Res Rev. 2011 Apr;10(2):181-90. doi: 10.1016/j.arr.2010.01.002. Epub 2010 Jan 28.
7
Biochemical and molecular mechanisms of aging: from model systems to human longevity. Preface.
Biochim Biophys Acta. 2009 Oct;1790(10):949-50. doi: 10.1016/j.bbagen.2009.08.009.
8
Biogerontology, "anti-aging medicine," and the challenges of human enhancement.
Hastings Cent Rep. 2003 Jul-Aug;33(4):21-30.
9
[Longevity is genetic luck: Interview with Dr. Béla Székács].
Orv Hetil. 2010 Apr 11;151(15):639. doi: 10.1556/OH.2010.15M.
10
Medical research: treat ageing.
Nature. 2014 Jul 24;511(7510):405-7. doi: 10.1038/511405a.
引用本文的文献
1
SENS vs. the hallmarks of aging: competing visions, shared challenges.
Biogerontology. 2025 May 5;26(3):103. doi: 10.1007/s10522-025-10248-5.
本文引用的文献
1
Science fact and the SENS agenda. What can we reasonably expect from ageing research?
EMBO Rep. 2005 Nov;6(11):1006-8. doi: 10.1038/sj.embor.7400555.
2
Resistance to debate on how to postpone ageing is delaying progress and costing lives. Open discussions in the biogerontology community would attract public interest and influence funding policy.
EMBO Rep. 2005 Jul;6 Spec No(Suppl 1):S49-53. doi: 10.1038/sj.embor.7400399.
3
Total deletion of in vivo telomere elongation capacity: an ambitious but possibly ultimate cure for all age-related human cancers.
Ann N Y Acad Sci. 2004 Jun;1019:147-70. doi: 10.1196/annals.1297.026.
4
The foreseeability of real anti-aging medicine: focusing the debate.
Exp Gerontol. 2003 Sep;38(9):927-34. doi: 10.1016/s0531-5565(03)00155-4.
5
Is human aging still mysterious enough to be left only to scientists?
Bioessays. 2002 Jul;24(7):667-76. doi: 10.1002/bies.10113.
6
Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.
Circulation. 2001 Sep 25;104(13):1464-70. doi: 10.1161/hc3801.097806.
Zotero 插件